Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Warner Chilcott 3Q profit drops despite purchases
Yahoo/AP
Monday, November 8, 2010 - 11:24am
tags:
Warner Chilcott, earnings
Vivus sells Muse assets for $23.5M
Bizjournals.com
Monday, November 8, 2010 - 10:51am
tags:
M&A, Muse, Vivus, Meda, erectile dysfunction
Allergan ($AGN) plots Botox promo for migraine use
Fierce Pharma
Monday, November 8, 2010 - 10:45am
tags:
migraines, Allergan, Botox
Boehringer Drug Lowers Bleeding Risk in Those Who Had Stroke
Bloomberg
Monday, November 8, 2010 - 10:43am
tags:
Boehringer Ingelheim, Pradaxa, blood thinners, stroke
When Is A Small Biotech Not Really So Small?
Pharmalot
Monday, November 8, 2010 - 10:42am
tags:
biotech, SIGA technologies, smallpox, HHS
King Pharma Disappoints
Yahoo/Zacks.com
Monday, November 8, 2010 - 10:41am
tags:
earnings, Pfizer, King
Dendreon's Dilemma Isn't Provenge Competition, Demand -- It's Geography
Minyanville
Monday, November 8, 2010 - 10:40am
tags:
Provenge, Dendreon, vaccines, prostate cancer
Abbott Labs: Strong Management, Balance Sheet, Growth and Dividends
Seeking Alpha
Monday, November 8, 2010 - 9:42am
tags:
Abbott Laboratories
Eli Lilly to buy Avid Radiopharmaceuticals
Marketwatch
Monday, November 8, 2010 - 9:40am
tags:
Avid, Eli Lilly, M&A
Cadence Pharma plans $85M public stock offering
Yahoo/AP
Monday, November 8, 2010 - 9:38am
tags:
Cadence Pharmaceuticals, stock offering
Amylin Pharmaceuticals CEO Discusses Q3 2010 Results - Earnings Call Transcript
Seeking Alpha
Monday, November 8, 2010 - 9:37am
tags:
Amylin, earnings
Bayer implements new branding strategy
Pharma Times, UK
Monday, November 8, 2010 - 9:36am
tags:
Bayer, branding
Allos Therapeutics CEO Discusses Q3 2010 Results - Earnings Call Transcript
Seeking Alpha
Monday, November 8, 2010 - 9:34am
tags:
earnings, Allos
What Is Avanir Pharmaceuticals Really Worth?
Seeking Alpha
Monday, November 8, 2010 - 9:33am
tags:
Avanir
Pfizer Arthritis Pill, First in New Family, Found Safe in Late-Stage Study
Bloomberg
Monday, November 8, 2010 - 9:31am
tags:
Pfizer, arthritis, tasocitinib
Depomed Posts Positive Earnings With Strong 2011 Outlook
Seeking Alpha
Monday, November 8, 2010 - 9:30am
tags:
earnings, Abbott Laboratories, Depomed
Teva sees $2.4b from respiratory operations by 2015
Globes, Israel
Sunday, November 7, 2010 - 11:54am
tags:
Teva Pharmaceuticals, Ventolin HFA, ProAir HFA, QNAZE, allergic rhinitis, Flonase, QVAR
Pharmasset Makes Remarkable Recovery on Hepatitis C Franchise
Seeking Alpha
Sunday, November 7, 2010 - 11:32am
tags:
Pharmasset, hepatitis C, nucleoside polymerase inhibitor, RG7128, Roche
Lilly Opens New Diabetes Research Center With Focus on China
Seeking Alpha
Sunday, November 7, 2010 - 11:30am
tags:
Eli Lilly, diabetes, China
A Small Step Back for MannKind?
Seeking Alpha
Sunday, November 7, 2010 - 11:29am
tags:
MannKind, inhaled insulin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.